weight loss medications

$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion

March 24, 2025 Marketdata LLC has just published a new report: “The U.S. Weight Loss Market: Commercial (non-medical) Programs & Products”, March 2025. This is a 220-page analysis of commercial weight loss programs/companies and how they have been affected by and respond to the onslaught of the GLP-1 drugs competition. The $38 billion U.S. commercial weight loss […]

$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion Read More »

Study finds that 42% of online pharmacies selling semaglutide are illegal

News / John LaRosa

August 14, 2024 Nearly half of online pharmacies that sell semaglutide — the active ingredient in Ozempic and Wegovy — are doing so illegally, posing safety risks for consumers, according to a study published Aug. 2 in JAMA Network Open. Of the 317 online pharmacies included in the study, researchers found 42.27% were operating illegally, meaning

Study finds that 42% of online pharmacies selling semaglutide are illegal Read More »

23 and me To Enter The Weight Loss Market

News / John LaRosa

August 13, 2024 As reported by Fiercehealthcare.com today in an article… The genetic testing company 23andMe sees an opportunity to get in on the weight loss boom. The company, through its Lemonaid Health business, plans to launch a GLP-1 weight loss telehealth membership by the end of the month, it announced last week along with

23 and me To Enter The Weight Loss Market Read More »

Nearly all patients quit weight loss shots within two years, study finds

News / John LaRosa

July 11, 2024 An article by Endpoints.com cited a study that found that only about 15% of people who began taking GLP-1 drugs such as Wegovy stuck with them after two years, according to a new analysis by pharmacy benefit manager Prime Therapeutics. Prime, which is owned by a group of Blue Cross Blue Shield

Nearly all patients quit weight loss shots within two years, study finds Read More »

Eli Lilly Offers Weight Loss Drug Direct to Consumers

News / John LaRosa

January 5, 2023 Eli Lilly and Company launched a website, lillydirect.com, to enable people to directly order from the drug maker including its weight-loss medicine Zepbound as well as connect people with obesity and other conditions with telehealth companies. The service, called LillyDirect, comes on the back on extraordinary demand seen over the last year

Eli Lilly Offers Weight Loss Drug Direct to Consumers Read More »

(813) 971-8080

$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion

Study finds that 42% of online pharmacies selling semaglutide are illegal

23 and me To Enter The Weight Loss Market

Nearly all patients quit weight loss shots within two years, study finds

Eli Lilly Offers Weight Loss Drug Direct to Consumers